Track topics on Twitter Track topics that are important to you
The Diopsys® Chromatic Flash Vision Screener is a simple-to-use and easy-to-integrate protocol within the Diopsys® ffERG / Full Field Electroretinography module. PINE BROOK, N.J. (PRWEB) Oct...
Diopsys helps spread diabetes awareness for WDD 2018 PINE BROOK, N.J. (PRWEB) November 14, 2018 In recognition of World Diabetes Day, Diopsys is lending its voice to the global diabetes community to ...
Glaucoma is a common and potentially blinding disease. It is characterized by an optic nerve damage, a visual field defect and elevated intraocular pressure (IOP). The loss of retinal ner...
The purpose of this study is to establish electrophysiological benchmarks, using the Diopsys Visual Evoked Potential/ Pattern Electroretinogram (VEP/PERG) protocols of populations with Gla...
The aim of this study was to evaluate structural and functional improvement following intraocular pressure (IOP) reductions in patients with glaucoma using Spectral Domain Optical Coherenc...
We have published hundreds of Diopsys news stories on BioPortfolio along with dozens of Diopsys Clinical Trials and PubMed Articles about Diopsys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Diopsys Companies in our database. You can also find out about relevant Diopsys Drugs and Medications on this site too.